COVID-19 Overview: Testing (Online CE Course)

(based on 579 customer ratings)

Author: David J Moffa, PhD, BCLD
Reviewers: Alexandru Casapu, MBA, MLS(ASCP)CM, PBTCM; Jenny Camele, MT(ASCP)

How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 178 CE courses, most popular
$109Add to cart
Pick Your Courses
Up to 8 CE hours
$55Add to cart
Individual course$25Add to cart
Need multiple seats for your university or lab? Get a quote

This course provides essential background information on COVID-19 with emphasis on various testing methodologies available for the identification/diagnosis of suspected COVID-19 infections. The course also discusses how to identify possible prior COVID-19 infections and provides useful information for epidemiological and research studies. In addition, the course emphasizes the difference between diagnostic (viral) tests and antibody (serology) tests when used for COVID-19 testing. Updated information on COVID-19 treatments including current updates on vaccines are also provided.

See all available courses

Continuing Education Credits

P.A.C.E.® Contact Hours (acceptable for AMT, ASCP, and state recertification): 1.5 hour(s)
Approved through 4/30/2024
Florida Board of Clinical Laboratory Personnel Credit Hours - General (Serology/Immunology): 1.5 hour(s)
Approved through 4/30/2024

Objectives

  • Describe the structure and characteristics of coronaviruses
  • Describe the diseases caused by coronaviruses
  • Discuss the COVID-19 emergence, transmission, symptoms and severity.
  • Discuss the prevention and treatment for COVID-19.
  • Review the current vaccines available for COVID-19.
  • Discuss the diagnosis of COVID-19 and the types of testing available.
  • Describe NAAT, Antigen tests, Serology tests and other COVID-19 tests.

Customer Ratings

(based on 579 customer ratings)

Course Outline

Click on the links below to preview selected pages from this course.
  • Coronavirus Background
  • Coronavirus disease 2019 (COVID-19).
      • Emergence and Transmission
      • Transmission
      • Symptoms and Severity
      • What do we know about the transmission of the COVID-19 infection? More than one answer may be correct.
      • Older people and individuals of all ages with medical conditions such as heart disease, diabetes, or lung disease may be at higher risk of developing ...
      • Prevention
      • Treatment
      • Treatment, continued
      • Treatment, continued
      • In late 2020, the FDA approved an antiviral drug to treat COVID-19. The drug is approved to treat adults and children ages 12 and older, weighing at l...
      • All of following treatments have been approved by the NIH for COVID-19 infections especially in hospitalized patients and more severely ill patients e...
      • COVID-19 Vaccines
      • COVID-19 Vaccines, continued
      • Vaccine Update: Additional Boosters
      • The Delta Variant and Omicron
      • Which statement(s) is true regarding COVID-19 vaccines in the U.S.?
      • Recently, the CDC approved and recommended a COVID-19 second vaccine booster shot for the Pfizer-BioNtech and Moderna vaccines and a booster for the J...
      • Which statement is true regarding the "delta variant"?
  • COVID-19 Diagnosis
  • COVID Testing
      • Emergency Use Authorization (EUA)
      • Types of COVID-19 Tests
      • Currently, a definitive diagnosis of COVID-19 is made using an Antibody (Serology) test to detect antibodies produced in response to the COVID-19 infe...
      • During the COVID-19 pandemic, the FDA can issue a special type of approval for a product, devise, test, or treatment without full FDA approval process...
    • Diagnostic (Viral) Tests
      • Diagnostic (Viral) Tests: Molecular Tests
      • Diagnostic (Viral) Tests: Antigen Tests
      • Diagnostic (Viral) Tests: Conclusions
      • Diagnostic (Viral) Tests: Methodology Overview
      • Diagnostic (Viral) Tests: Methodology Overview, continued
      • Diagnostic (Viral) Tests: Methodology Overview, continued
      • Diagnostic (Viral) Tests: Methodology, continued
      • Diagnostic (Viral) Tests: Methodology, continued
      • All of the following statements are correct when describing Molecular Tests for COVID-19 except
      • Antigen tests for COVID-19 infection are typically immunoassays that detect a specific viral antigen and are used to indicate current COVID-19 infecti...
      • Which statements correctly describe Antigen Tests?
    • Antibody (Serology) Tests
      • Antibody (Serology) Tests
      • Antibody (Serology) Tests, continued
      • Which statements correctly describe Antibody (Serology) Tests for COVID-19?
      • Which method is currently used to perform the Antibody (serology) screening test for COVID-19?
    • Other COVID-19 Tests
      • Point of Care (POC) Tests and “At Home” Testing
      • Point of Care (POC) Tests and "At-Home" Testing, continued
      • Point of Care (POC) Tests and "At-Home" Testing, continued
      • Point-of-Care tests for COVID-19 are performed at or near where specimens are collected with results obtained within minutes rather than hours or seve...
      • All of the following statements correctly describe "At Home" Testing for COVID-19 except
      • The BinaxNOW Ag Card test is a commonly used at-home self-test to detect the SARS-CoV-2 nucleocapsid protein from nasal swabs. What specific methodolo...
  • Commercially Available COVID-19 Tests
      • Examples of Commercial COVID-19 Tests
      • Examples of Commercial COVID-19 Tests, continued
      • Match the type of COVID-19 test to the commercial test!
      • All of the following statements correctly describe the Bioperfectus COVID-19 real-time RT-PCR test except
      • Which test is a two-step enzyme chemiluminescent immunoassay that uses paramagnetic particles to detect IgG antibodies to the SARS-CoV-2 virus?
  • Summary and Key Facts
  • References
      • References

Additional Information

Level of Instruction: Intermediate
Intended Audience: Clinical laboratory professionals including medical laboratory scientists, medical technologists, and technicians. This course is also appropriate for clinical laboratory science and MLT students, pathologists, and clinicians.
Author Information: David J. Moffa, PhD, BCLD, has over 30 years of experience in the healthcare industry as an executive manager, clinical laboratory director, and medical laboratory scientist. He is currently a technical consultant for Kentmere Healthcare, Wilmington, DE, and until his retirement, was the Regional Director for LabCorp, Inc. He holds a PhD in medical biochemistry from the School of Medicine, West Virginia University.
Reviewer Information:
Alexandru Casapu, MBA, MLS(ASCP)CM, PBTCM has over 20 years of experience as a medical laboratory scientist, section supervisor, and laboratory manager. He is the former Director of Clinical Laboratory Technology Program at Georgia Piedmont Technical College. He is currently a Program Director at MediaLab, Inc. Alexandru holds BS degrees in Biology and Medical Technology from Clark Atlanta University and a MBA from the University of Georgia.
Prior to her retirement in 2012, Jenny Camele was employed by Laboratory Corporation of America as the manager of customer service operations for the Fairmont West Virginia Region and a Quality Assurance committee member. She holds a Bachelor of Science degree in Medical Technology from West Virginia University.
Course Description: This course provides essential background information on COVID-19 with emphasis on various testing methodologies available for the identification/diagnosis of suspected COVID-19 infections and to help identify possible prior COVID-19 infections and provide useful information for epidemiological and research studies. In addition, the course emphasizes the difference between diagnostic (viral) tests and antibody (serology) tests when used for COVID-19 testing. Updated information on COVID-19 treatments including current updates on vaccines are also provided. 

How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 178 CE courses, most popular
$109Add to cart
Pick Your Courses
Up to 8 CE hours
$55Add to cart
Individual course$25Add to cart
Need multiple seats for your university or lab? Get a quote
Overview of RT-PCR: The technique uses RNA as the nucleic acid starting material which serves as the template for synthesis of complementary DNA (cDNA) using the enzyme, RNA-dependent DNA polymerase. The newly synthesized cDNA is then subjected to amplification and detection using PCR method. (3)


Overview of PCR Method: The main steps include Denaturation, Annealing, and Elongation to synthesize or amplify producing billions of copies of the DNA. (2)


Overview of LFIA: A liquid sample or extract with the analyte is applied to sample pad and moves laterally by capillary flow through zones which have attached molecules such as antibodies conjugated to colored or fluorescent particles. The test line is read as positive if the analyte is present. (5)